Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(-) chronic hepatitis B patients (study ETV-027)

被引：20

作者：

Shouval, D.

Akarca, U. S.

Hatzis, G.

Kitis, G.

Lai, C. L.

Cheinquer, H.

Chang, T. T.

Zink, R.

Zhu, J.

Brett-Smith, H.

机构：

[1] Hadassah Univ Hosp, Hadassah Med Org, Jerusalem, Israel

[2] Ege Univ, Fac Med, Div Gastroenterol, Izmir, Turkey

[3] Laikon Gen Hosp, Dept Pathophysiol, Athens, Greece

[4] George Papanikolaou Gen Hosp Thessaloniki, Dept Gastroenterol, Thessaloniki, Greece

[5] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China

[6] Univ Fed Rio Grande Sul, Porto Alegre, RS, Brazil

[7] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan

[8] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

来源：

关键词：

D O I：

10.1016/S0168-8278(06)80046-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S21 / S22

页数：2